Table 1.
The clinicopathological characteristics of 243 patients with HCC
| Variable | Cohort 1 (N = 71) (%) | Cohort 2 (N = 172) (%) | ||||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| Age (Mean age ± SD)(y),range | 49.08 ± 7.73 (18–62) | 46.28 ± 8.87 (28–71) | ||||
| Gender | ||||||
| Male | 54 | 76.06 | 150 | 87.21 | ||
| Female | 17 | 23.94 | 22 | 12.79 | ||
| Viral infection | ||||||
| HBV DNA-positive | 46 | 64.79 | 105 | 61.05 | ||
| HBeAg-positive | 28 | 39.44 | 66 | 38.37 | ||
| Child-Pugh classification | ||||||
| Class A | 62 | 87.32 | 161 | 93.60 | ||
| Class B | 9 | 12.68 | 11 | 6.40 | ||
| Tumour size | ||||||
| <3.8 cm | 33 | 46.47 | 93 | 54.07 | ||
| ≥3.8 cm | 38 | 53.52 | 79 | 45.93 | ||
| Number of nodules | ||||||
| Single | 63 | 88.73 | 144 | 83.72 | ||
| ≥2 | 8 | 11.26 | 28 | 16.28 | ||
| Tumour differentiation | ||||||
| well | 10 | 14.08 | 35 | 20.35 | ||
| mediately | 18 | 25.35 | 58 | 33.72 | ||
| poorly | 43 | 60.56 | 79 | 45.93 | ||
| BCLC stage | ||||||
| stage A | 36 | 50.7 | 81 | 47.09 | ||
| stage B | 35 | 49.29 | 91 | 52.91 | ||
| AFP | ||||||
| ≤400 ng/ml | 48 | 67.61 | 96 | 55.81 | ||
| >400 ng/ml | 23 | 32.39 | 76 | 44.19 | ||